The Singapore Cancer Registry Annual Report (2022) presents data on trends for incidence, mortality, and survival of cancer in Singapore from 1968-2022¹. Currently, cancer is the leading cause of death in Singapore, accounting for 27.1% of all deaths from 2018-2022¹.

In 2018-2022, prostate (17.4% of cancers in males), colorectal (16.2%) and lung (13.4%) cancers were the three most frequent incident cancers diagnosed in males, while breast (29.6% of cancers in females), colorectal, (12.9%) and lung (7.9%) cancers were the three most common cancer diagnoses in females¹.

In terms of mortality, lung (24.4% of cancer deaths in males), colorectal (14.3%), and liver (12.3%) cancers were the three leading contributors of cancer deaths in males, while breast (17.1% of cancer deaths in females), colorectal (15.6%), and lung (15.1%) cancers accounted for the most cancer deaths among females¹.

Early diagnosis, optimised treatments and successful management of adverse events to improve patient’s quality of life play an important role in managing this disease. Find out more about the recent advances in this field and what you can do to improve outcomes for your patients.